Bioterrorism Assay Expedited Review Backed By House Med Tech Caucus
This article was originally published in The Gray Sheet
Executive Summary
Roche will submit an investigational device exemption to FDA the week of Nov. 19 for a one-hour anthrax assay developed in collaboration with the Mayo Clinic
You may also be interested in...
Rule Change Frees Unapproved Tests To Play Bigger Role In Emergencies
FDA is amending its regulations to make it easier for a physician to test a patient for possible exposure to a terrorism-based or other infectious disease agent with an unapproved diagnostic without prior informed consent
High-Tech Devices, Representatives Excluded From HHS Bioterror Plans
Device industry reps are working with FDA to determine which types of products remain unaddressed by HHS Secretary Tommy Thompson's bioterrorism command center
High-Tech Devices, Representatives Excluded From HHS Bioterror Plans
Device industry reps are working with FDA to determine which types of products remain unaddressed by HHS Secretary Tommy Thompson's bioterrorism command center